<s>
Influenza_NN1 A_ZZ1 virus_NN1 causes_VVZ pandemics_NN2 as_CSA continued_JJ selective_JJ pressure_NN1 from_II the_AT immune_JJ response_NN1 causes_VVZ frequent_JJ mutations_NN2 at_II antigenic_JJ sites_NN2 ._. 
</s>
<s>
These_DD2 accumulate_VV0 most_RGT frequently_RR in_II the_AT five_MC epitopes_NN2 of_IO the_AT haemagglutinin_NN1 subunit_NN1 ,_, forcing_VVG the_AT immune_JJ response_NN1 to_TO alter_VVI to_TO achieve_VVI virus_NN1 clearance_NN1 ._. 
</s>
<s>
Occasionally_RR ,_, genetic_JJ reassortment_NN1 can_VM occur_VVI between_II two_MC co-circulating_JJ influenza_NN1 strains_NN2 ._. 
</s>
<s>
New_JJ haemagglutinin_NN1 and_CC neuraminidase_VV0 subtypes_NN2 are_VBR acquired_VVN ,_, resulting_VVG in_II antigenic_JJ shift_NN1 and_CC substantial_JJ mortality_NN1 due_II21 to_II22 the_AT lack_NN1 of_IO pre-existing_JJ immunity_NN1 ._. 
</s>
<s>
This_DD1 laboratory_NN1 investigation_NN1 demonstrated_VVD the_AT fundamental_JJ assays_NN2 ,_, haemagglutination_NN1 assay_NN1 ,_, haemagglutination_NN1 inhibition_NN1 assay_NN1 and_CC infectivity_NN1 assay_NN1 aid_NN1 influenza_NN1 characterisation_NN1 ._. 
</s>
<s>
It_PPH1 was_VBDZ demonstrated_VVN that_CST antigenic_JJ drift_NN1 can_VM happen_VVI gradually_RR if_CS one_MC1 epitope_NN1 mutation_NN1 is_VBZ selected_VVN for_IF at_II a_AT1 time_NNT1 ._. 
</s>
<s>
If_CS two_MC epitopes_NN2 are_VBR selected_VVN ,_, the_AT virus_NN1 is_VBZ completely_RR neutralised_VVN ._. 
</s>
<s>
Influenza_NN1 A_ZZ1 is_VBZ a_AT1 major_JJ pathogen_NN1 and_CC a_AT1 leading_JJ cause_NN1 of_IO death_NN1 in_II infants_NN2 ,_, the_AT immunocompromised_JJ and_CC the_AT elderly_JJ 9_MC ._. 
</s>
<s>
In_II the_AT US_NP1 alone_RR ,_, an_AT1 average_NN1 of_IO 51,000_MC deaths_NN2 occurs_VVZ annually_RR due_II21 to_II22 influenza_NN1 18_MC ._. 
</s>
<s>
This_DD1 highly_RR contagious_JJ respiratory_JJ disease_NN1 causes_VVZ pandemics_NN2 and_CC epidemics_NN2 resulting_VVG in_II high_JJ mortality_NN1 and_CC morbidity_NN1 ,_, which_DDQ could_VM be_VBI prevented_VVN through_II vaccination_NN1 ._. 
</s>
<s>
The_AT 1918_MC pandemic_JJ of_IO H1N1_FO is_VBZ ranked_VVN as_CSA one_MC1 of_IO the_AT three_MC most_RGT destructive_JJ human_JJ epidemics_NN2 with_IW a_AT1 death_NN1 toll_NN1 approximately_RR 25_MC million_NNO 15_MC ._. 
</s>
<s>
It_PPH1 is_VBZ estimated_VVN that_CST the_AT annual_JJ epidemics_NN2 have_VH0 had_VHN a_AT1 more_RGR significant_JJ impact_NN1 on_II human_JJ health_NN1 than_CSN the_AT three_MC pandemics_NN2 combined_VVD 16_MC ._. 
</s>
<s>
Since_II 1918_MC ,_, the_AT other_JJ pandemics_NN2 have_VH0 been_VBN H2N2_FO 1957_MC ,_, H3N2_FO 1968_MC and_CC H1N1_FO again_RT in_II 1977_MC 11_MC ._. 
</s>
<s>
It_PPH1 is_VBZ believed_VVN that_CST we_PPIS2 are_VBR overdue_JJ for_IF another_DD1 pandemic_JJ 19_MC ._. 
</s>
<s>
The_AT threat_NN1 of_IO a_AT1 new_JJ pandemic_JJ is_VBZ believed_VVN to_TO come_VVI from_II 'bird_NN1 flu'_NN1 or_CC H5N1_FO ._. 
</s>
<s>
Influenza_NN1 strain_VV0 A/Hong_FU Kong/156/97_FU initially_RR appeared_VVD in_II Hong_NP1 Kong_NP1 in_II 1997_MC from_II crossing_VVG the_AT species_NN barrier_NN1 from_II birds_NN2 to_II humans_NN2 7_MC ._. 
</s>
<s>
Since_II then_RT it_PPH1 has_VHZ resulted_VVN in_II the_AT culling_NN1 of_IO millions_NNO2 of_IO birds_NN2 ,_, 147_MC human_JJ cases_NN2 with_IW 78_MC deaths_NN2 20_MC ._. 
</s>
<s>
As_RR21 yet_RR22 ,_, H5N1_FO has_VHZ yet_RR to_TO acquire_VVI mutation(s)_NN2 which_DDQ would_VM allow_VVI efficient_JJ transmission_NN1 between_II humans_NN2 ._. 
</s>
<s>
As_II the_AT virus_NN1 is_VBZ already_RR demonstrating_VVG resistance_NN1 to_II the_AT anti-viral_JJ drug_NN1 amantadine_NN1 7_MC ,_, the_AT pressure_NN1 to_TO develop_VVI a_AT1 vaccine_NN1 against_II H5N1_FO is_VBZ rising_VVG ._. 
</s>
<s>
Influenza_NN1 viruses_NN2 are_VBR classified_VVN within_II the_AT orthomyxovirus_NN1 family_NN1 ,_, figure_NN1 2.1_MC ._. 
</s>
<s>
There_EX are_VBR three_MC main_JJ types_NN2 A_ZZ1 ,_, B_ZZ1 and_CC C_ZZ1 of_IO which_DDQ A_ZZ1 and_CC B_ZZ1 cause_VV0 serious_JJ disease_NN1 16_MC ._. 
</s>
<s>
Influenza_NN1 A_ZZ1 is_VBZ classified_VVN into_II subtypes_NN2 based_VVN upon_II the_AT degree_NN1 of_IO homology_NN1 between_II the_AT haemagglutinin_NN1 (_( HA_UH )_) and_CC neuraminidase_NN1 (_( NA_FW )_) surface_NN1 proteins_NN2 4_MC ._. 
</s>
<s>
The_AT 16_MC subtypes_NN2 of_IO HA_UH and_CC 9_MC of_IO NA_FW 2_MC generate_VV0 144_MC different_JJ virus_NN1 combinations_NN2 which_DDQ can_VM and_CC potentially_RR cause_VV0 disease_NN1 ._. 
</s>
<s>
The_AT main_JJ antigenic_JJ sites_NN2 are_VBR the_AT three_MC envelope_NN1 proteins_NN2 ,_, of_IO which_DDQ ,_, HA_UH and_CC NA_FW are_VBR the_AT most_RGT important_JJ ._. 
</s>
<s>
M1_FO is_VBZ the_AT least_RGT antigenic_JJ of_IO these_DD2 ,_, forming_VVG proton_NN1 channels_NN2 which_DDQ span_VV0 the_AT envelope_NN1 6_MC ._. 
</s>
<s>
The_AT HA_UH protein_NN1 trimer_NN1 has_VHZ an_AT1 important_JJ role_NN1 in_II viral_JJ entry_NN1 and_CC uncoating_VVG 15_MC ,_, figure_NN1 2.2_MC ,_, and_CC binds_VVZ to_II sialic_JJ acid_NN1 on_II the_AT cell_NN1 surface_NN1 allowing_VVG fusion_NN1 to_TO occur_VVI ._. 
</s>
<s>
NA_FU cleaves_VVZ the_AT terminal_JJ N-acetyl_JJ acid_NN1 or_CC sialic_JJ acid_NN1 by_II a_AT1 hydrolysis_NN1 reaction_NN1 ._. 
</s>
<s>
This_DD1 is_VBZ important_JJ for_IF viral_JJ egress_NN1 as_CSA it_PPH1 allows_VVZ the_AT removal_NN1 of_IO surface_NN1 sialic_JJ acid_NN1 at_II the_AT release_NN1 site_NN1 to_TO prevent_VVI binding_VVG upon_II budding_JJ and_CC subsequent_JJ re-infection_NN1 of_IO the_AT cell_NN1 ._. 
</s>
<s>
HA_UH and_CC NA_FU proteins_NN2 are_VBR the_AT main_JJ antigenic_JJ sites_NN2 targeted_VVN by_II the_AT adaptive_JJ response_NN1 ._. 
</s>
<s>
The_AT five_MC antigenic_JJ sites_NN2 on_II the_AT HA_UH protein_NN1 8_MC ,_, figure_NN1 2.2_MC ,_, elicit_VV0 a_AT1 neutralising_NN1 antibody_NN1 response_NN1 ._. 
</s>
<s>
Regular_JJ selection_NN1 pressure_NN1 from_II antibodies_NN2 and_CC the_AT lack_NN1 of_IO proof_NN1 reading_NN1 ability_NN1 in_II the_AT viral_JJ RNA_NN1 polymerase_NN1 4_MC leads_VVZ to_II an_AT1 accumulation_NN1 of_IO sense_NN1 mutations_NN2 in_II the_AT HA_UH sequence_NN1 which_DDQ enable_VV0 the_AT virus_NN1 to_TO evade_VVI the_AT immune_JJ response_NN1 and_CC infect_VVI susceptible_JJ hosts_NN2 ._. 
</s>
<s>
This_DD1 finding_NN1 was_VBDZ confirmed_VVN by_II Knossow_NP1 et_RA21 al_RA22 in_II 1984_MC whose_DDQGE X-ray_NN1 crystallography_NN1 data_NN illustrated_VVD that_CST escape_VV0 mutants_NN2 have_VH0 very_RG small_JJ changes_NN2 in_II HA_UH structure_NN1 ._. 
</s>
<s>
This_DD1 antigenic_JJ variability_NN1 is_VBZ termed_VVN antigenic_JJ drift_NN1 and_CC is_VBZ characterised_VVN by_II the_AT acquisition_NN1 of_IO less_DAR than_CSN four_MC amino_NN1 acid_NN1 changes_NN2 in_II two_MC different_JJ antigenic_JJ sites_NN2 4_MC ,_, 12_MC ._. 
</s>
<s>
Antigenic_JJ shift_NN1 is_VBZ essentially_RR the_AT reassortment_NN1 of_IO genetic_JJ material_NN1 of_IO two_MC influenza_NN1 viruses_NN2 from_II different_JJ species_NN upon_II co-infection_NN1 of_IO a_AT1 host_NN1 ._. 
</s>
<s>
Unpredictable_JJ recombination_NN1 results_NN2 in_II the_AT acquisition_NN1 of_IO a_AT1 new_JJ H_ZZ1 or_CC N_ZZ1 subtypes_VVZ to_II which_DDQ the_AT population_NN1 is_VBZ unlikely_JJ to_TO have_VHI pre-existing_JJ immunity_NN1 4_MC ._. 
</s>
<s>
Of_IO the_AT 144_MC possible_JJ serotypes_NN2 ,_, we_PPIS2 have_VH0 only_RR been_VBN exposed_VVN to_II four_MC ._. 
</s>
<s>
Although_CS not_XX all_DB combinations_NN2 may_VM cause_VVI pandemics_NN2 ,_, influenza_NN1 still_RR remains_VVZ a_AT1 significant_JJ threat_NN1 to_II human_JJ health_NN1 ._. 
</s>
<s>
This_DD1 laboratory_NN1 focuses_VVZ upon_II the_AT H1N1_FO influenza_NN1 virus_NN1 A/PR/8/34_FU (_( PR8_FO )_) ,_, isolated_VVN in_II 1934_MC and_CC attenuated_VVN due_II21 to_II22 repeated_JJ passaging_NN1 in_II embryonated_JJ chicken_NN1 eggs_NN2 ._. 
</s>
<s>
The_AT aims_NN2 of_IO the_AT laboratory_NN1 are_VBR outlined_VVN in_II the_AT laboratory_NN1 manual_NN1 13_MC ._. 
</s>
<s>
The_AT experimental_JJ procedures_NN2 are_VBR described_VVN in_II detail_NN1 in_II the_AT laboratory_NN1 manual_NN1 13_MC ._. 
</s>
<s>
There_EX was_VBDZ one_MC1 change_NN1 to_II the_AT materials_NN2 used_VVN in_II the_AT final_JJ sequence_NN1 purification_NN1 step_NN1 in_II experiment_NN1 8_MC ,_, which_DDQ involved_VVD the_AT addition_NN1 of_IO blue_JJ dye_NN1 separately_RR to_II the_AT reaction_NN1 mixture_NN1 rather_II21 than_II22 with_IW the_AT acetate_NN1 ._. 
</s>
<s>
Eggs_NN2 were_VBDR inoculated_VVN with_IW antibiotics_NN2 in_II proximity_NN1 to_II a_AT1 Bunsen_NP1 ,_, equipment_NN1 was_VBDZ flamed_VVN ,_, needle_NN1 tips_NN2 were_VBDR changed_VVN regularly_RR and_CC improvements_NN2 in_II personal_JJ technique_NN1 all_RR helped_VVN to_TO minimise_VVI contamination_NN1 over_II the_AT laboratory_NN1 investigation_NN1 ._. 
</s>
<s>
Out_II21 of_II22 the_AT many_DA2 eggs_NN2 inoculated_VVD ,_, two_MC were_VBDR contaminated_VVN whereas_CS a_AT1 few_DA2 others_NN2 produced_VVD small_JJ volumes_NN2 of_IO allantoic_JJ fluid_NN1 ._. 
</s>
<s>
The_AT HA_UH assay_NN1 enables_VVZ the_AT amount_NN1 of_IO viruses_NN2 in_II a_AT1 sample_NN1 to_TO be_VBI quantified_VVN in_II HA_UH units/ml_FU ._. 
</s>
<s>
Erythrocytes_NN2 express_VV0 sialic_JJ acid_NN1 on_II their_APPGE surface_NN1 ,_, to_II which_DDQ influenza_NN1 binds_VVZ using_VVG the_AT HA_UH protein_NN1 allowing_VVG cross_NN1 linking_VVG to_TO occur_VVI ._. 
</s>
<s>
If_CS insufficient_JJ virus_NN1 is_VBZ present_JJ ,_, inadequate_JJ cross_NN1 linking_NN1 occurs_VVZ causing_VVG erythrocyte_NN1 precipitation_NN1 ._. 
</s>
<s>
HA_UH binding_JJ to_II sialic_JJ acid_NN1 resulted_VVN in_II the_AT agglutination_NN1 of_IO the_AT erythrocytes_NN2 at_II low_JJ virus_NN1 dilutions_NN2 ,_, figure_NN1 4.1_MC ._. 
</s>
<s>
The_AT averaged_JJ end_NN1 point_NN1 for_IF PR8_FO was_VBDZ 746.6_MC HAU/100_FU l_NNU equivalent_JJ to_II 7466_MC HAU/ml_FU ._. 
</s>
<s>
Infectious_JJ units_NN2 are_VBR calculated_VVN by_II multiplying_VVG this_DD1 value_NN1 by_II 10_MC 6_MC ,_, giving_VVG 7.466x10_FO 9IU/ml_FU ._. 
</s>
<s>
This_DD1 value_NN1 is_VBZ quantitative_JJ allowing_VVG comparisons_NN2 between_II IU_NP1 values_NN2 of_IO other_JJ viruses_NN2 ,_, allowing_VVG a_AT1 universal_JJ concentration_NN1 of_IO virus_NN1 to_TO be_VBI calculated_VVN so_RR haemagglutinin_NN1 inhibition_NN1 assays_NN2 can_VM be_VBI performed_VVN ._. 
</s>
<s>
The_AT HI_UH assay_NN1 demonstrates_VVZ the_AT ability_NN1 of_IO a_AT1 virus_NN1 to_TO agglutinate_VVI erythrocytes_NN2 and_CC the_AT efficacy_NN1 of_IO an_AT1 antibody_NN1 to_TO inhibit_VVI this_DD1 17_MC ._. 
</s>
<s>
It_PPH1 calculates_VVZ the_AT antibody_NN1 titre_NN1 required_VVN to_TO inhibit_VVI 50%_NNU agglutination_NN1 of_IO 160HAU/ml_FU of_IO virus_NN1 ._. 
</s>
<s>
The_AT HI_UH end_VV0 point_NN1 was_VBDZ calculated_VVN between_II the_AT two_MC virus_NN1 dilutions_NN2 ,_, resulting_VVG in_II 96_MC HIU/100_FU l_NNU ,_, thus_RR 960HIU/ml_FU ._. 
</s>
<s>
This_DD1 indicates_VVZ that_CST 960_MC HIU/ml_FU of_IO MAb1_FO is_VBZ required_VVN to_TO inhibit_VVI 160HAU/ml_FU of_IO PR8_FO ._. 
</s>
<s>
Virus_NN1 replication_NN1 is_VBZ not_XX efficient_JJ thus_RR not_XX all_DB cultured_JJ virus_NN1 will_VM be_VBI infectious_JJ ._. 
</s>
<s>
The_AT infectivity_NN1 assay_NN1 determines_VVZ the_AT titre_NN1 of_IO virus_NN1 needed_VVD to_TO infect_VVI 50%_NNU of_IO the_AT inoculated_JJ eggs_NN2 ,_, ID_NN1 50_MC ,_, as_CSA the_AT virus_NN1 is_VBZ diluted_VVN until_CS it_PPH1 is_VBZ no_RR21 longer_RR22 infectious_JJ ._. 
</s>
<s>
Figure_NN1 4.3_MC illustrates_VVZ the_AT ID_NN1 50_MC of_IO PR8_FO ,_, calculated_VVD using_VVG the_AT following_JJ equation_NN1 ._. 
</s>
<s>
Log10_FO ID_NN1 50/inoculum_FU volume_NN1 =_FO highest_JJT dilution_NN1 tested_VVN +_FO (_( half_DB the_AT dilution_NN1 interval_NN1 )_) -_- (_( sum_NN1 of_IO virus_NN1 negative_JJ egg_NN1 at_II each_DD1 dilution/number_NN1 of_IO eggs_NN2 inoculated_VVD )_) ._. 
</s>
<s>
The_AT infectivity_NN1 assay_NN1 generated_VVD ambiguous_JJ data_NN for_IF the_AT virus_NN1 diluted_VVN to_II 10_MC -7_MC as_CSA more_DAR eggs_NN2 produced_VVD agglutination_NN1 in_II 10_MC -8_MC than_CSN 10_MC -7_MC dilution_NN1 ,_, figure_NN1 4.3._MC 10_MC -7_MC was_VBDZ therefore_RR not_XX included_VVN in_II the_AT final_JJ ID_NN1 50_MC calculation_NN1 ._. 
</s>
<s>
NA_UH ,_, a_AT1 type_NN1 2_MC capsid_JJ glycoprotein_NN1 ,_, cleaves_VVZ sialic_JJ acid_NN1 to_II glycoproteins_NN2 and_CC glycolipids_NN2 ._. 
</s>
<s>
Its_APPGE activity_NN1 can_VM be_VBI measured_VVN quantitatively_RR using_VVG serum_NN1 glycoprotein_NN1 fetuin_NN1 to_TO generate_VVI a_AT1 coloured_JJ compound_NN1 ,_, which_DDQ can_VM be_VBI measured_VVN spectrophotometrically_RR ._. 
</s>
<s>
Between_II 0_MC and_CC 6_MC hours_NNT2 ,_, NA_FU works_VVZ optimally_RR in_II the_AT existing_JJ conditions_NN2 causing_VVG the_AT amount_NN1 of_IO cleaved_JJ fetuin_NN1 to_TO increase_VVI exponentially_RR ,_, figure_NN1 4.4_MC ._. 
</s>
<s>
As_CSA incubation_NN1 time_NNT1 increases_NN2 ,_, free_JJ fetuin_NN1 decreases_VVZ ,_, causing_VVG less_DAR substrate_NN1 to_TO be_VBI available_JJ for_IF cleavage_NN1 by_II NA_FU ._. 
</s>
<s>
Catalytic_JJ activity_NN1 decreases_VVZ causing_VVG a_AT1 curve_NN1 which_DDQ could_VM plateau_NN1 if_CS incubation_NN1 time_NNT1 was_VBDZ continued_VVN ,_, as_CSA all_DB substrate_NN1 would_VM be_VBI cleaved_VVN by_II NA_FU ._. 
</s>
<s>
An_AT1 anomalous_JJ result_NN1 at_II 6_MC hours_NNT2 was_VBDZ omitted_VVN from_II the_AT graph_NN1 ._. 
</s>
<s>
The_AT value_NN1 did_VDD not_XX fit_VVI the_AT trend_NN1 observed_VVN and_CC may_VM have_VHI occurred_VVN due_II21 to_II22 inaccurate_JJ pipetting_NN1 ,_, mixing_VVG and_CC blanking_VVG ._. 
</s>
<s>
The_AT density_NN1 and_CC velocity_NN1 gradients_NN2 allow_VV0 the_AT separation_NN1 of_IO components_NN2 from_II a_AT1 mixed_JJ sample_NN1 ._. 
</s>
<s>
This_DD1 technique_NN1 is_VBZ often_RR used_VVN to_TO separate_VVI virus_NN1 particles_NN2 from_II patient_JJ serum_NN1 for_IF further_JJR identification_NN1 through_II PCR_NP1 or_CC ELISA_NP1 ._. 
</s>
<s>
Upon_II centrifugation_NN1 ,_, the_AT samples_NN2 travelled_VVD a_AT1 distance_NN1 appropriate_JJ to_II their_APPGE density_NN1 ._. 
</s>
<s>
Crbcs_NP1 settled_VVD at_II an_AT1 average_NN1 of_IO 2.55cm_NNU and_CC mrbcs_NNU at_II 2_MC cm_NNU ,_, indicating_VVG an_AT1 equilibrium_NN1 had_VHD been_VBN reached_VVN ,_, where_CS the_AT density_NN1 inside_RL and_CC outside_II the_AT cells_NN2 was_VBDZ equal_JJ ._. 
</s>
<s>
Reading_NP1 accuracy_NN1 increased_VVN as_II the_AT samples_NN2 settled_VVN as_II the_AT bands_NN2 were_VBDR clearer_JJR ._. 
</s>
<s>
Crbcs_NP1 travelled_VVD further_RRR down_RP the_AT gradient_NN1 than_CSN mrbcs_NNU indicating_VVG that_CST crbcs_NNU are_VBR denser_JJR ._. 
</s>
<s>
A_AT1 velocity_NN1 gradient_NN1 allows_VVZ the_AT sedimentation_NN1 coefficient_NN1 to_TO be_VBI calculated_VVN which_DDQ is_VBZ dependent_JJ upon_II cell_NN1 mass_NN1 ,_, density_NN1 and_CC shape_NN1 ._. 
</s>
<s>
The_AT crbcs_NNU pelleted_VVD between_II two_MC and_CC seven_MC minutes_NNT2 whereas_CS mrbcs_NNU pelleted_VVD between_II seven_MC and_CC twelve_MC minutes_NNT2 ._. 
</s>
<s>
This_DD1 experiment_NN1 demonstrated_VVD antigenic_JJ drift_NN1 in_II PR8_FO through_II growth_NN1 cycles_NN2 in_II eggs_NN2 each_DD1 with_IW a_AT1 neutralising_NN1 MAb_NP1 directed_VVD against_II one_MC1 of_IO the_AT five_MC HA_UH antigenic_JJ sites_NN2 ._. 
</s>
<s>
The_AT four_MC best_JJT fluids_NN2 were_VBDR analysed_VVN as_CSA they_PPHS2 were_VBDR plentiful_JJ ,_, and_CC contamination_NN1 free_JJ ._. 
</s>
<s>
Appendix_NN1 3_MC illustrates_VVZ the_AT HA_UH results_NN2 for_IF MAb1_FO ._. 
</s>
<s>
The_AT second_MD virus_NN1 sample_NN1 did_VDD not_XX contain_VVI virus_NN1 whereas_CS the_AT first_MD and_CC third_MD virus_NN1 samples_NN2 did_VDD with_IW end_NN1 points_NN2 of_IO 1/5120_MF ._. 
</s>
<s>
Therefore_RR ,_, the_AT samples_NN2 contained_VVD virus_NN1 at_II 51200_MC HAU/ml_FU ,_, with_IW 5.12x10_FO 10IU/ml_FU ._. 
</s>
<s>
The_AT fourth_MD virus_NN1 sample_NN1 end_NN1 point_NN1 was_VBDZ 1/7680_MF and_CC contained_JJ virus_NN1 at_II 76800_MC HAU/ml_FU ,_, with_IW 7.68x10_FO 10IU/ml_FU ._. 
</s>
<s>
For_IF the_AT first_MD replicate_VV0 at_II 1/5120_MF dilution_NN1 an_AT1 end_NN1 point_NN1 was_VBDZ observed_VVN but_CCB was_VBDZ discounted_VVN as_CSA this_DD1 well_RR contained_VVD more_DAR blood_NN1 ._. 
</s>
<s>
Appendix_NN1 4_MC illustrates_VVZ the_AT mini_NN1 HA_UH and_CC HI_UH performed_VVN on_II the_AT first_MD and_CC third_MD virus_NN1 samples_NN2 ._. 
</s>
<s>
This_DD1 demonstrated_VVD that_DD1 virus_NN1 sample_NN1 1_MC1 was_VBDZ not_XX neutralised_VVN by_II MAb1_FO whereas_CS sample_NN1 3_MC did_VDD show_VVI a_AT1 possible_JJ end_NN1 point_NN1 in_II dilution_NN1 ._. 
</s>
<s>
This_DD1 result_NN1 indicated_VVD that_CST both_DB2 virus_NN1 samples_NN2 have_VH0 been_VBN successfully_RR mutated_VVN at_II a_AT1 HA_UH antigenic_JJ site_NN1 to_TO allow_VVI escape_NN1 from_II neutralising_VVG MAb1_FO ._. 
</s>
<s>
PR8_FO control_NN1 was_VBDZ inhibited_VVN at_II 960_MC HIU/ml_FU ._. 
</s>
<s>
From_II these_DD2 experiments_NN2 the_AT virus_NN1 sample_NN1 1_MC1 was_VBDZ mixed_VVN with_IW MAb2_FO and_CC MAb1_FO in_II an_AT1 attempt_NN1 to_TO generate_VVI a_AT1 double_JJ escape_NN1 mutant_NN1 ._. 
</s>
<s>
MAb1_FO was_VBDZ included_VVN to_TO ensure_VVI the_AT maintenance_NN1 of_IO the_AT mutated_JJ epitope_NN1 ._. 
</s>
<s>
Appendix_NN1 5_MC illustrates_VVZ the_AT HA_UH results_NN2 for_IF double_JJ escape_NN1 mutants_NN2 ._. 
</s>
<s>
Virus_NN1 samples_VVZ one_MC1 and_CC two_MC were_VBDR calculated_VVN to_TO have_VHI 1.024x10_FO 11IU/ml_FU whereas_CS virus_NN1 samples_NN2 three_MC and_CC four_MC were_VBDR calculated_VVN to_TO have_VHI 5.12x10_FO 10_MC IU/ml_FU ._. 
</s>
<s>
Appendix_NN1 6_MC illustrates_VVZ the_AT HA_UH results_NN2 for_IF MAb1_FO and_CC MAb2_FO double_JJ escape_NN1 mutants_NN2 for_IF PR8_FO ._. 
</s>
<s>
No_AT agglutination_NN1 of_IO erythrocytes_NN2 was_VBDZ observed_VVN ._. 
</s>
<s>
These_DD2 experiments_NN2 demonstrate_VV0 that_CST double_JJ escape_NN1 mutants_NN2 can_VM be_VBI generated_VVN if_CS inhibited_VVN at_II a_AT1 single_JJ epitope_NN1 per_II growth_NN1 cycle_NN1 to_TO allow_VVI for_IF mutants_NN2 to_TO replicate_VVI ._. 
</s>
<s>
Figure_NN1 4.7_MC illustrates_VVZ that_DD1 virus_NN1 samples_NN2 two_MC and_CC three_MC produced_VVD double_JJ escape_NN1 mutants_NN2 as_CSA these_DD2 samples_NN2 were_VBDR not_XX inhibited_VVN by_II MAb2_FO ._. 
</s>
<s>
The_AT possible_JJ end_NN1 point_NN1 for_IF virus_NN1 sample_NN1 one_MC1 at_II dilution_NN1 was_VBDZ discounted_VVN as_II the_AT duplicate_JJ value_NN1 caused_VVD agglutination_NN1 ._. 
</s>
<s>
PR8_FO required_VVN MAb2_FO at_II 960_MC HIU/ml_FU to_TO successfully_RR be_VBI inhibited_VVN ._. 
</s>
<s>
Appendix_NN1 8_MC illustrates_VVZ the_AT data_NN collated_VVD from_II the_AT class_NN1 results_NN2 ._. 
</s>
<s>
In_II all_DB experiments_NN2 performed_VVN for_IF the_AT antigenic_JJ drift_NN1 assay_NN1 ,_, all_DB viruses_NN2 initially_RR isolated_VVN in_II HA_UH assays_NN2 for_IF both_DB2 MAb1_FO and_CC MAb1_FO and_CC MAb2_FO were_VBDR found_VVN to_TO be_VBI true_JJ mutants_NN2 whereas_CS all_DB the_AT wild_JJ type_NN1 double_JJ mutants_NN2 were_VBDR unable_JK to_TO be_VBI isolated_VVN ._. 
</s>
<s>
The_AT specific_JJ region_NN1 of_IO the_AT HA_UH molecule_NN1 which_DDQ MAb1_FO and_CC MAb2_FO were_VBDR directed_VVN against_II was_VBDZ determined_VVN through_II sequencing_NN1 of_IO single_JJ escape_NN1 mutant_NN1 virus_NN1 1_MC1 and_CC double_JJ escape_NN1 mutant_NN1 virus_NN1 3_MC ._. 
</s>
<s>
Appendices_NN2 9-13_MCMC illustrate_VV0 the_AT sequence_NN1 data_NN for_IF PR8_FO ,_, single_JJ and_CC double_JJ escape_NN1 mutants_NN2 respectively_RR ._. 
</s>
<s>
The_AT mutation_NN1 at_II amino_NN1 acid_NN1 residue_NN1 97_MC which_DDQ allowed_VVD the_AT MAb1_FO mutant_NN1 to_TO escape_VVI neutralising_NN1 antibody_NN1 was_VBDZ conserved_VVN in_II the_AT sequence_NN1 of_IO MAb2_FO escape_NN1 mutant_NN1 ._. 
</s>
<s>
MAb2_FO escape_NN1 mutant_NN1 had_VHD an_AT1 additional_JJ mutation_NN1 at_II residue_NN1 85_MC which_DDQ allowed_VVD it_PPH1 to_TO escape_VVI neutralising_VVG MAb2_FO ._. 
</s>
<s>
The_AT mutated_JJ residues_NN2 97_MC and_CC 85_MC for_IF MAb1_FO and_CC MAb2_FO respectively_RR equate_VV0 to_II residues_NN2 152_MC and_CC 140_MC in_II two_MC different_JJ antigenic_JJ sites_NN2 of_IO HA_UH ._. 
</s>
<s>
This_DD1 demonstrates_VVZ that_CST two_MC mutations_NN2 at_II the_AT different_JJ epitopes_NN2 targeted_VVN by_II the_AT antibodies_NN2 were_VBDR required_VVN for_IF the_AT virus_NN1 to_TO escape_VVI ._. 
</s>
<s>
Influenza_NN1 possesses_VVZ several_DA2 characteristics_NN2 which_DDQ can_VM be_VBI exploited_VVN for_IF use_NN1 in_II identification_NN1 and_CC quantitative_JJ techniques_NN2 ._. 
</s>
<s>
Chicken_NN1 eggs_NN2 provide_VV0 an_AT1 appropriate_JJ culture_NN1 system_NN1 for_IF cheaply_RR producing_VVG high_JJ yields_NN2 ,_, with_IW minimal_JJ contamination_NN1 ._. 
</s>
<s>
They_PPHS2 contain_VV0 2,3_MC NANA_NN1 not_XX human_JJ 2,6_MC NANA_NN1 which_DDQ induces_VVZ mutations_NN2 in_II the_AT HA_UH protein_NN1 to_TO allow_VVI efficient_JJ growth_NN1 ._. 
</s>
<s>
However_RR ,_, not_XX all_DB influenza_NN1 virus_NN1 strains_NN2 replicate_VV0 efficiently_RR in_II eggs_NN2 8_MC ,_, therefore_RR it_PPH1 would_VM be_VBI ideal_JJ to_TO develop_VVI a_AT1 mammalian_JJ cell_NN1 culture_NN1 system_NN1 allowing_VVG rapid_JJ growth_NN1 and_CC reduced_VVD harvesting_VVG time_NNT1 ._. 
</s>
<s>
Currently_RR ,_, no_AT such_DA system_NN1 exists_VVZ which_DDQ permits_VVZ cost_NN1 effective_JJ production_NN1 of_IO high_JJ viral_JJ titres_NN2 ._. 
</s>
<s>
HA_UH subtypes_NN2 can_VM be_VBI identified_VVN using_VVG HA_UH and_CC HI_UH assays_NN2 ,_, rapidly_RR ,_, cheaply_RR and_CC reproducibly_RR to_II a_AT1 high_JJ degree_NN1 of_IO accuracy_NN1 and_CC thus_RR are_VBR advantageous_JJ over_II PCR_NP1 or_CC Elisa_NP1 's_GE ._. 
</s>
<s>
When_CS compared_VVN to_II infectivity_NN1 assays_NN2 ,_, HA_UH 's_GE are_VBR used_VVN preferentially_RR as_CSA fewer_DAR resources_NN2 are_VBR needed_VVN ,_, they_PPHS2 are_VBR less_RGR complicated_JJ and_CC live_JJ virus_NN1 need_VM not_XX be_VBI used_VVN ,_, reducing_VVG infection_NN1 risk_NN1 ._. 
</s>
<s>
Both_DB2 assays_NN2 produce_VV0 comparable_JJ data_NN ,_, which_DDQ may_VM not_XX occur_VVI for_IF other_JJ viruses_NN2 ._. 
</s>
<s>
However_RR ,_, variation_NN1 may_VM arise_VVI due_II21 to_II22 experimental_JJ differences_NN2 such_II21 as_II22 egg_NN1 batches_NN2 ._. 
</s>
<s>
The_AT infectivity_NN1 assay_NN1 generated_VVD anomalous_JJ results_NN2 ,_, figure_NN1 4.3_MC ._. 
</s>
<s>
This_DD1 may_VM have_VHI occurred_VVN due_II21 to_II22 contamination_NN1 as_II the_AT yolks_NN2 looked_VVD abnormal_JJ and_CC the_AT harvested_JJ% fluid_NN1 was_VBDZ of_IO low_JJ volume_NN1 ,_, dark_JJ and_CC cloudy_JJ ._. 
</s>
<s>
Secondly_RR ,_, the_AT 10_MC -7_MC eggs_NN2 were_VBDR inoculated_VVN last_MD to_TO prevent_VVI viral_JJ carry_VV0 over_RP from_II low_JJ to_II high_JJ virus_NN1 dilutions_NN2 therefore_RR less_DAR care_NN1 may_VM have_VHI been_VBN taken_VVN in_II maintaining_VVG sterility_NN1 and_CC technique_NN1 ._. 
</s>
<s>
Thirdly_RR ,_, the_AT virus_NN1 may_VM have_VHI settled_VVN in_II the_AT Eppendorf_NP1 and_CC the_AT solution_NN1 was_VBDZ not_XX thoroughly_RR mixed_VVN before_II injecting_VVG ,_, leading_VVG to_II a_AT1 greater_JJR proportion_NN1 of_IO PBS_NP1 being_VBG injected_VVN than_CSN virus_NN1 ._. 
</s>
<s>
Finally_RR ,_, a_AT1 higher_JJR virus_NN1 dilution_NN1 may_VM have_VHI been_VBN inoculated_VVN into_II these_DD2 eggs_NN2 ,_, causing_VVG ambiguous_JJ data_NN for_IF 10_MC -7_MC ._. 
</s>
<s>
When_CS compared_VVN to_II the_AT HA_UH assay_NN1 ,_, figure_NN1 4.1_MC ,_, 7.466x10_FO 9_MC IU/ml_FU was_VBDZ obtained_VVN for_IF infectious_JJ units_NN2 whereas_CS in_II the_AT infectivity_NN1 assay_NN1 10_MC 9.1ID_FO 50/ml_FU was_VBDZ calculated_VVN ._. 
</s>
<s>
The_AT values_NN2 are_VBR very_RG similar_JJ ,_, both_DB2 being_VBG in_II the_AT range_NN1 of_IO 10_MC 9_MC therefore_RR experimental_JJ differences_NN2 such_II21 as_II22 different_JJ egg_NN1 batches_NN2 ,_, contamination_NN1 and_CC concentration_NN1 variations_NN2 may_VM have_VHI led_VVN to_II the_AT slight_JJ difference_NN1 between_II the_AT values_NN2 ._. 
</s>
<s>
HA_UH assays_NN2 give_VV0 total_JJ counts_NN2 regardless_RR of_IO whether_CSW the_AT virus_NN1 is_VBZ infectious_JJ or_CC not_XX ,_, whereas_CS infectivity_NN1 assays_NN2 provide_VV0 an_AT1 end_NN1 point_NN1 of_IO infectivity_NN1 as_II the_AT virus_NN1 is_VBZ diluted_VVN ._. 
</s>
<s>
Therefore_RR both_DB2 samples_NN2 contain_VV0 a_AT1 similar_JJ proportion_NN1 of_IO infectious_JJ virus_NN1 ._. 
</s>
<s>
From_II these_DD2 experiments_NN2 it_PPH1 can_VM be_VBI concluded_VVN that_CST the_AT HA_UH assay_NN1 provides_VVZ accurate_JJ ,_, comparable_JJ data_NN for_IF determining_JJ infectivity_NN1 of_IO a_AT1 virus_NN1 titre_NN1 and_CC the_AT titre_NN1 needed_VVD to_TO cause_VVI 50%_NNU agglutination_NN1 ._. 
</s>
<s>
HI_UH assays_NN2 can_VM rapidly_RR characterise_VVI influenza_NN1 subtypes_VVZ if_CS multiple_JJ experiments_NN2 are_VBR conducted_VVN simultaneously_RR ,_, using_VVG specific_JJ antibodies_NN2 ._. 
</s>
<s>
Calculation_NN1 of_IO HAU/ml_FU enables_VVZ antibody_NN1 optimisation_NN1 whilst_CS allowing_VVG comparisons_NN2 to_TO be_VBI made_VVN between_II different_JJ antibody_NN1 efficacies_NN2 to_TO inhibit_VVI the_AT same_DA virus_NN1 ._. 
</s>
<s>
HA_UH and_CC HI_UH assays_NN2 can_VM be_VBI straightforwardly_RR adapted_VVN to_TO allow_VVI high_JJ throughput_NN1 analysis_NN1 ,_, invaluable_JJ when_CS developing_VVG therapeutic_JJ agents_NN2 or_CC characterising_VVG many_DA2 samples_NN2 ._. 
</s>
<s>
However_RR ,_, serological_JJ characterisation_NN1 of_IO influenza_NN1 strains_NN2 does_VDZ not_XX distinguish_VVI between_II viral_JJ groups_NN2 or_CC indicate_VV0 that_CST an_AT1 antibody_NN1 does_VDZ not_XX bind_VVI 7_MC ._. 
</s>
<s>
Progressive_JJ antigenic_JJ drift_NN1 results_NN2 in_II a_AT1 few_DA2 mutations_NN2 which_DDQ may_VM not_XX be_VBI detected_VVN by_II the_AT antibody_NN1 used_VVD ,_, these_DD2 are_VBR only_RR detected_VVN by_II sequencing_NN1 and_CC molecular_JJ analysis_NN1 ._. 
</s>
<s>
The_AT NA_FU activity_NN1 assay_NN1 ,_, density_NN1 gradient_NN1 and_CC velocity_NN1 gradient_NN1 experiments_NN2 reinforced_VVD understanding_NN1 of_IO influenza_NN1 properties_NN2 and_CC common_JJ virology_NN1 techniques_NN2 ._. 
</s>
<s>
Experiment_NN1 6_MC demonstrated_VVD that_CST crbcs_NNU are_VBR denser_JJR than_CSN mrbcs_NNU because_CS crbcs_NNU are_VBR nucleated_VVN ,_, DNA_NN1 is_VBZ heavier_JJR than_CSN protein_NN1 and_CC as_RG mrbcs_NNU lose_VV0 their_APPGE nucleus_NN1 during_II maturity_NN1 ,_, crbcs_NNU will_VM travel_VVI further_RRR down_RP the_AT gradient_NN1 ._. 
</s>
<s>
Crbcs_NP1 and_CC mrbcs_NNU differ_VV0 in_II mass_NN1 ,_, density_NN1 and_CC shape_NN1 ,_, crbcs_NNU are_VBR denser_JJR ,_, have_VH0 more_DAR mass_NN1 due_II21 to_II22 a_AT1 nucleus_NN1 and_CC are_VBR slightly_RR larger_JJR and_CC oval_NN1 ._. 
</s>
<s>
Therefore_RR the_AT velocity_NN1 gradient_NN1 demonstrated_VVD that_CST crbcs_NNU have_VH0 a_AT1 greater_JJR sedimentation_NN1 value_NN1 and_CC pellet_NN1 faster_RRR than_CSN mrbcs_NNU ._. 
</s>
<s>
For_IF both_DB2 the_AT velocity_NN1 and_CC density_NN1 gradients_NN2 ,_, another_DD1 faint_JJ band_NN1 was_VBDZ seen_VVN in_II the_AT mrbcs_NNU samples_NN2 as_CSA some_DD cells_NN2 may_VM still_RR have_VHI contained_VVN a_AT1 nucleus_NN1 ._. 
</s>
<s>
Experiment_NN1 7_MC demonstrated_VVD that_CST escape_VV0 mutant_NN1 virus_NN1 9_MC generated_VVD a_AT1 possible_JJ end_NN1 point_NN1 against_II MAb1_FO ._. 
</s>
<s>
This_DD1 may_VM have_VHI occurred_VVN due_II21 to_II22 blood_NN1 volume_NN1 differences_NN2 or_CC most_RGT likely_JJ ,_, steric_JJ inhindrence_NN1 of_IO MAb1_FO ,_, which_DDQ may_VM still_RR be_VBI able_JK to_TO bind_VVI to_II the_AT particle_NN1 preventing_VVG agglutination_NN1 from_II occurring_VVG ._. 
</s>
<s>
The_AT five_MC antigenic_JJ sites_NN2 of_IO HA_UH provoke_VV0 a_AT1 neutralising_NN1 immune_JJ response_NN1 ._. 
</s>
<s>
As_CSA figure_NN1 5.1_MC demonstrates_VVZ ,_, a_AT1 single_JJ mutation_NN1 was_VBDZ generated_VVN in_II the_AT MAb1_FO escape_NN1 mutant_NN1 at_II residue_NN1 97_MC ._. 
</s>
<s>
However_RR ,_, the_AT sequence_NN1 data_NN was_VBDZ ambiguous_JJ ,_, appendices_NN2 10_MC and_CC 11_MC ,_, demonstrating_VVG equal_JJ fluorescence_NN1 for_IF a_AT1 G_ZZ1 or_CC T_ZZ1 nucleotide_VV0 at_II this_DD1 position_NN1 ._. 
</s>
<s>
This_DD1 may_VM indicate_VVI a_AT1 population_NN1 of_IO two_MC mutants_NN2 in_II the_AT sample_NN1 or_CC an_AT1 ambiguous_JJ result_NN1 ,_, which_DDQ may_VM require_VVI repeat_VV0 sequencing_NN1 ._. 
</s>
<s>
Residue_NN1 97_MC maps_NN2 to_II residue_NN1 152_MC located_VVD in_II the_AT Sb_NP1 antigenic_JJ site_NN1 of_IO HA_UH ._. 
</s>
<s>
MAb2_FO escape_NN1 mutant_NN1 encoded_VVD a_AT1 valine_NN1 at_II position_NN1 97_MC and_CC a_AT1 glutamic_JJ acid_NN1 residue_NN1 at_II position_NN1 85_MC ._. 
</s>
<s>
This_DD1 indicates_VVZ that_CST the_AT double_JJ escape_NN1 mutant_NN1 was_VBDZ formed_VVN from_II either_RR the_AT valine_NN1 MAb1_FO mutant_NN1 population_NN1 or_CC that_CST the_AT sequence_NN1 data_NN was_VBDZ ambiguous_JJ but_CCB was_VBDZ in_II fact_NN1 valine_NN1 ._. 
</s>
<s>
Glutamic_JJ acid_NN1 at_II residue_NN1 85_MC maps_NN2 to_II residue_NN1 140_MC ,_, which_DDQ is_VBZ between_II residues_NN2 139_MC and_CC 141_MC in_II the_AT Ca2_FO antigenic_JJ site_NN1 of_IO HA_UH ._. 
</s>
<s>
When_CS wild-type_NN1 PR8_FO was_VBDZ incubated_VVN with_IW MAb1_FO and_CC MAb2_FO simultaneously_RR ,_, the_AT harvested_JJ% virus_NN1 was_VBDZ neutralised_VVN whereas_CS when_CS escape_NN1 mutants_NN2 were_VBDR generated_VVN using_VVG neutralising_NN1 antibody_NN1 directed_VVN against_II one_MC1 epitope_NN1 at_II one_MC1 time_NNT1 ,_, double_JJ escape_NN1 mutants_NN2 were_VBDR generated_VVN ._. 
</s>
<s>
This_DD1 occurred_VVD because_CS when_CS two_MC neutralising_NN1 antibodies_NN2 are_VBR directed_VVN against_II two_MC different_JJ epitopes_NN2 ,_, the_AT virus_NN1 would_VM need_VVI to_TO mutate_VVI at_II these_DD2 two_MC sites_NN2 simultaneously_RR ._. 
</s>
<s>
This_DD1 event_NN1 is_VBZ extremely_RR rare_JJ and_CC therefore_RR it_PPH1 was_VBDZ expected_VVN that_CST a_AT1 double_JJ mutant_NN1 for_IF wild-type_NN1 PR8_FO could_VM not_XX be_VBI produced_VVN in_II one_MC1 incubation_NN1 step_NN1 ._. 
</s>
<s>
Influenza_NN1 evades_VVZ the_AT immune_JJ response_NN1 by_II mutations_NN2 in_II its_APPGE major_JJ antigenic_JJ epitopes_NN2 ._. 
</s>
<s>
It_PPH1 is_VBZ proposed_VVN ,_, that_DD1 mapping_NN1 changes_NN2 in_II these_DD2 regions_NN2 will_VM allow_VVI future_JJ antigenic_JJ drift_NN1 to_TO be_VBI predicted_VVN ._. 
</s>
<s>
Currently_RR several_DA2 models_NN2 ,_, mathematical_JJ and_CC graphical_JJ have_VH0 been_VBN proposed_VVN 1_MC1 ,_, 9_MC ,_, 10_MC ,_, 14_MC ,_, 17_MC ,_, which_DDQ rely_VV0 on_II gradual_JJ antigenic_JJ change_NN1 to_TO generate_VVI escape_NN1 mutants_NN2 9_MC ,_, 17_MC ._. 
</s>
<s>
Identification_NN1 of_IO these_DD2 crucial_JJ epitopes_NN2 will_VM narrow_VVI the_AT search_NN1 for_IF candidate_NN1 vaccine_NN1 strains_VVZ 9_MC and_CC allow_VV0 understanding_NN1 of_IO the_AT virus_NN1 evolution_NN1 and_CC therapeutic_JJ design_NN1 to_TO stay_VVI ahead_RL ._. 
</s>
<s>
Vaccination_NN1 has_VHZ the_AT potential_JJ to_TO decrease_VVI transmission_NN1 ,_, causing_VVG a_AT1 decrease_NN1 in_II frequency_NN1 of_IO further_JJR antigenic_JJ drift_NN1 1_MC1 ._. 
</s>
<s>
The_AT HA1_FO region_NN1 of_IO H3N2_FO changes_NN2 at_II a_AT1 rate_NN1 of_IO 6_MC nucleotides_NN2 substitution_NN1 per_II genome_NN1 per_II year_NNT1 10_MC thus_RR ,_, it_PPH1 is_VBZ essential_JJ that_CST these_DD2 sites_NN2 are_VBR identified_VVN in_II both_RR this_DD1 and_CC other_JJ influenza_NN1 subtypes_VVZ to_TO allow_VVI effective_JJ vaccine_NN1 production_NN1 ._. 
</s>
<s>
However_RR ,_, circulating_VVG subtypes_NN2 must_VM still_RR be_VBI monitored_VVN as_II 95%_NNU of_IO strains_NN2 survive_VV0 less_DAR than_CSN 1_MC1 year_NNT1 and_CC infect_VV0 few_DA2 people_NN 5_MC and_CC thus_RR ,_, influenza_NN1 's_GE dynamic_JJ nature_NN1 may_VM still_RR result_VVI in_II regular_JJ vaccine_NN1 updation_NN1 ._. 
</s>
<s>
Due_II21 to_II22 the_AT rigorous_JJ selection_NN1 pressures_NN2 imposed_VVN upon_II this_DD1 virus_NN1 by_II our_APPGE immune_JJ system_NN1 and_CC the_AT threat_NN1 of_IO a_AT1 pandemic_JJ looming_JJ imminently_RR ,_, the_AT need_NN1 to_TO develop_VVI tissue_NN1 culture_NN1 systems_NN2 for_IF virus_NN1 production_NN1 and_CC a_AT1 cross-protecting_JJ vaccine_NN1 may_VM enable_VVI us_PPIO2 to_TO control_VVI this_DD1 disease_NN1 rather_CS21 than_CS22 cure_VVI it_PPH1 ._. 
</s>
<s>
Influenza_NN1 virus_NN1 will_VM continue_VVI to_TO pose_VVI a_AT1 significant_JJ threat_NN1 to_II human_JJ health_NN1 ._. 
</s>
<s>
Antigenic_JJ shift_NN1 and_CC progressive_JJ antigenic_JJ drift_NN1 allows_VVZ influenza_NN1 to_TO evade_VVI the_AT immune_JJ system_NN1 and_CC develop_VVI resistance_NN1 to_II anti-virals_NN2 and_CC vaccines_NN2 ._. 
</s>
<s>
This_DD1 laboratory_NN1 investigation_NN1 successfully_RR demonstrated_VVN that_CST antigenic_JJ drift_NN1 occurs_VVZ gradually_RR against_II a_AT1 single_JJ selective_JJ pressure_NN1 at_II a_AT1 time_NNT1 ._. 
</s>
<s>
The_AT outbreak_NN1 of_IO SARS_NP2 highlighted_VVD how_RGQ prepared_JJ we_PPIS2 were_VBDR for_IF an_AT1 outbreak_NN1 of_IO a_AT1 respiratory_JJ infection_NN1 ._. 
</s>
<s>
However_RR ,_, influenza_NN1 is_VBZ more_RGR easily_RR transmitted_VVN and_CC unlikely_JJ to_TO be_VBI controlled_VVN through_II screening_NN1 and_CC quarantine_NN1 measures_NN2 alone_RR 4_MC ._. 
</s>
<s>
Intercontinental_JJ travel_NN1 is_VBZ likely_JJ to_TO exacerbate_VVI the_AT problem_NN1 ,_, therefore_RR the_AT race_NN1 to_TO develop_VVI a_AT1 protective_JJ vaccine_NN1 to_TO overcome_VVI influenza_NN1 and_CC its_APPGE progressive_JJ antigenic_JJ drift_NN1 has_VHZ never_RR been_VBN so_RG important_JJ ._. 
</s>
